| RS2496653611 |
MRE11
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496653723 |
MRE11
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496653918 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496655165 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS2496655318 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496656641 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496656680 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS2496656745 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496656801 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496657019 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496658982 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496659071 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496659335 |
ACAT1
|
Health Risk |
Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2496659813 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496659881 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS2496659888 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS2496660796 |
PHF21A
|
Health Risk |
Likely pathogenic |
— |
| RS2496662886 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2496662893 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496663079 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496663221 |
ABCC8
|
Health Risk |
Likely pathogenic |
Diabetes mellitus, permanent neonatal 3 |
| RS2496663250 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496663439 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496663531 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2496663699 |
ABCC8
|
Health Risk |
Likely pathogenic |
— |
| RS2496663744 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496663754 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496663759 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496664032 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496664131 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496667151 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2496667489 |
MRE11
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS2496667722 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Diabetes mellitus, permanent neonatal 3 |
| RS2496668119 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2496668297 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496668328 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496668596 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS2496668620 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2496668696 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496668989 |
ABCC8
|
Health Risk |
Likely pathogenic |
— |
| RS2496670154 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS2496670236 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496670286 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496670715 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496670866 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496670899 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496671115 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2496672003 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2496672554 |
ABCC8
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2496672672 |
ABCC8
|
Health Risk |
Likely pathogenic |
— |
| RS2496672683 |
ABCC8
|
Health Risk |
Likely pathogenic |
— |
| RS2496674822 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496675044 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496675352 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496675394 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496675449 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496675458 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS2496675487 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496675586 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496675771 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496675773 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496675835 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2496675867 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496676087 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2496687937 |
ABCC8
|
Health Risk |
Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2496688509 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2496689814 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2496711460 |
TYR
|
Health Risk |
Pathogenic |
— |
| RS2496711543 |
TYR
|
Health Risk |
Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN |
| RS2496711997 |
TYR
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 1B, Oculocutaneous albinism type 1A |
| RS2496712080 |
TYR
|
Health Risk |
Likely pathogenic |
— |
| RS2496712146 |
TYR
|
Health Risk |
Pathogenic |
TYR-related disorder, TYR-related disorder |
| RS2496717956 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS2496718398 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS2496722228 |
C2CD3
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome type 14, Orofaciodigital syndrome type 14 |
| RS2496726431 |
TYR
|
Health Risk |
Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN |
| RS2496728342 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2496729081 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2496731085 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2496741202 |
KCNQ1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Long QT syndrome |
| RS2496741235 |
LRP5
|
Health Risk |
Likely pathogenic |
— |
| RS2496741590 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2496741859 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Congenital long QT syndrome, Congenital long QT syndrome |
| RS2496742137 |
KCNQ1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2496742355 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS2496742945 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS2496743195 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2496744582 |
MYO7A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Usher syndrome type 1B |
| RS2496744948 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2496745583 |
MYO7A
|
Health Risk |
Likely pathogenic |
Auditory neuropathy, Auditory neuropathy |
| RS2496746746 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496748155 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2496748177 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2496748386 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2496748689 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2496750905 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2496752260 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2496752969 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2496755272 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2496755478 |
ABCC8
|
Health Risk |
Pathogenic |
— |